tyrosine has been researched along with Motor Neuron Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccitto, M; Clardy, J; Driscoll, M; Georgiades, SN; Kalb, RG; Liu, Y; Mano, I; Merry, D; Mojsilovic-Petrovic, J; Nedelsky, N; Neve, RL; Taylor, JP; Zhou, W | 1 |
| Banerjee, P; Berry-Kravis, E; Boyers, MJ; Dawson, G | 1 |
| Beal, MF; Ferrante, RJ; Gurney, ME; Kowall, NW; Matthews, RT; Schulz, JB; Shinobu, LA; Thomas, CE | 1 |
| Duncan, MW; Gurney, ME; Pamphlett, R; Poljak, A | 1 |
| Halliwell, B; Hyun, DH; Jenner, P; Lee, M | 1 |
5 other study(ies) available for tyrosine and Motor Neuron Disease
| Article | Year |
|---|---|
FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.
Topics: Animals; Blotting, Western; Cell Count; Cell Culture Techniques; Cell Death; Computational Biology; Disease Models, Animal; Drosophila; Embryo, Mammalian; Excitatory Amino Acid Agonists; Female; Fluorescence; Forkhead Box Protein O3; Forkhead Transcription Factors; Immunohistochemistry; Kainic Acid; Mice; Mice, Inbred C57BL; Motor Neuron Disease; Motor Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord; Tyrosine | 2009 |
Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient.
Topics: Adult; Alleles; Amino Acid Sequence; Animals; beta-N-Acetylhexosaminidases; Cell Line; Exons; Female; Genetic Carrier Screening; Hexosaminidase A; Hexosaminidase B; Humans; Macromolecular Substances; Male; Motor Neuron Disease; Point Mutation; Protein Structure, Secondary; Sandhoff Disease; Serine; Transfection; Tyrosine | 1994 |
Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.
Topics: Analysis of Variance; Animals; Cerebral Cortex; Copper; Heme Oxygenase (Decyclizing); Humans; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Mutant Strains; Mice, Transgenic; Motor Neuron Disease; Point Mutation; Protein Binding; Spinal Cord; Superoxide Dismutase; Tyrosine; Zinc | 1997 |
Measurement of o- and m-tyrosine as markers of oxidative damage in motor neuron disease.
Topics: Animals; Biomarkers; Brain Chemistry; Humans; Isomerism; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Neuron Disease; Muscle, Skeletal; Spinal Cord; Superoxide Dismutase; Tyrosine | 2000 |
Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and pro
Topics: Aldehydes; Amino Acid Substitution; Cell Death; Cell Survival; Cross-Linking Reagents; Culture Media, Serum-Free; Genes, bcl-2; Guanine; Humans; Hydrogen Peroxide; Kinetics; Lipid Peroxidation; Motor Neuron Disease; Mutagenesis, Site-Directed; Neuroblastoma; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Superoxide Dismutase; Superoxide Dismutase-1; Teratocarcinoma; Tumor Cells, Cultured; Tyrosine | 2001 |